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Background: Partial nephrectomy has been underutilized in the United States. We investigated national trends in
partial nephrectomy (PN) utilization before and after publication of the American Urological Association (AUA)
Practice Guideline for management of the clinical T1 renal mass.
Methods: We identified adult patients who underwent radical (RN) or PN from November 2007 to October 2011 in
the Nationwide Inpatient Sample (NIS). PN prevalence was calculated prior to (11/2007-10/2009) and after
Guidelines publication (11/2009-10/2011) and compared the rate of change by linear regression. We also examined
the nephrectomy trends in patients with chronic kidney disease (CKD). Statistical analysis included linear regression
to determine point-prevalence of PN rates in CKD patients and logistic regression to identify variables associated
with PN.
Results: During the study period, 30,944 patients underwent PN and 64,767 RN. The prevalence PN increased from
28.9% in the years prior to guideline release to 35.3% in the years following guideline release with an adjusted
odds ratio (OR) of 1.24 (CI 1.01–1.54; p = 0.049). The rate of PN significantly increased throughout the study period
(R2 0.15, p = 0.006): however, the rate of change was not increased after the guidelines. (p = 0.46). Overall rate of PN
in patients with CKD did not increase over time (R2 0.0007, p = 0.99).
Conclusion: We noted a 6.4% absolute increase in PN after release of the AUA guidelines on clinical T1 renal mass
was published; however, the rate of increase was not likely associated with guideline release. The rate of PN
performed is increasing; however, further investigation regarding medical decision-making surrounding PN is
needed.
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Radical nephrectomy (RN) had been the standard of care
for renal malignancy for nearly 4 decades [1]. However,
increasing detection of small renal masses (SRM) has
lead to a stage migration of renal masses [2,3]. Smaller
tumors suggest the opportunity perform more nephron* Correspondence: iderweesh@gmail.com
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unless otherwise stated.sparing surgery; however, large national databases have
suggested underutilization of PN [4-7].
Increased knowledge of chronic cardiac and metabolic
sequelae of RN, along with data suggesting oncologic
equivalence for partial (PN) compared to radical neph-
rectomy for SRM, has prompted reconsideration of
surgical approaches to renal masses [8-14]. In 2009,
the American Urological Association (AUA) published
evidence-based practices guidelines for the management
of clinical T1a renal masses as a guide for clinicians to
consider PN to be the reference standard for T1a renalis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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vation in patients with chronic kidney disease (CKD) [15].
To investigate the potential shorter-term impact of
publication of the AUA T1 Renal Mass Guidelines, we
analyzed the overall and rate of utilization of PN versus
radical nephrectomy (RN) in a national cohort before
and after the AUA Guideline release, with a focused ana-




As the primary outcome, we investigated the proportion
and rate of PN performed after the release of the AUA T1
Renal Mass Guidelines compared to prior using a publicly
available cross-sectional inpatient database (National In-
patient Sample, NIS). Patients were divided into two
groups consisting of a 2-year span prior to and 2 year after
the release of the AUA T1 Renal Mass Guidelines. A sec-
ondary outcome is to investigate the rates of RN vs. PN in
patients with non-dialysis dependent chronic kidney dis-
ease (CKD) [ICD 9 code for CKD stages 3–4; i.e. glomeru-
lar filtration rate (GFR) of 59–31 and 30–15 ml/min/
1.73 m2, respectively)] in both time periods. Additionally,
we investigated patient and external factors associated
with performance of RN vs. PN in order to identify poten-
tial changes in disparities regarding utilization of nephron
sparing surgery and the possible factors associated with
patient selection.
Database cohort: the nationwide inpatient sample
We analyzed data from November 2009 to October 2011
in the Nationwide Inpatient Sample (NIS), which is part
of the Healthcare Cost and Utilization Project (HCUP)
sponsored by the Agency for Healthcare Research and
Quality (AHRQ). The database is de-identified and publi-
cally available; therefore, is exempt from formal IRB re-
view. It is the largest all-payer inpatient care database that
is publicly available in the United States, containing data
from 5 to 8 million hospital stays per year. In 2010, data
included 1,056 hospitals located in 42 states, making up a
20% stratified sample of U.S. hospitals [12]. Inpatient stay
records include clinical and resource use information
available from discharge abstracts. Weighted sampling al-
lows estimates for national trends. The data is publically
available and de-identified so no patient consent was
needed for this study. The NIS is available for purchase at
http://www.hcup-us.ahrq.gov/nisoverview.jsp.
Variables
We focused on age, Charlson comorbidity index, and CKD
as specific variables, which are emphasized in with the
AUA clinical T1 Renal Mass Guidelines. However, CKD
coding in the NIS can be non-specific for stage dependingon how the medical history was coded. Therefore, we will
use the CKD codes for a general term CKD with subse-
quent sub analysis of specifically CKD stage 3 and 4 (eGFR
range of 15–59). Other abstracted exposure variables in-
cluded race, gender, treatment year, income by zip code,
geographic region of treatment (Northeast, South, Midwest,
and West), hospital renal surgery volume, insurance type,
the hospital size, hospital location (rural vs. urban), and
hospital type (teaching versus non-teaching).
Case selection
General
We identified all hospital admissions in patients older
than 18 years with a primary or secondary procedure
code for PN (PN) (55.4) or radical nephrectomy (RN)
(55.5, 55.51, 55.52 and 55.54) from November 2007 to
October 2011.
Oncologic extent
The NIS does not contain tumor size or disease specific
staging. Additionally, patients with locally advanced,
locoregional or metastatic disease are more likely to
undergo RN. Therefore, we excluded patients undergo-
ing concomitant surgeries suggestive of advanced dis-
ease, including splenectomy (41.4, 41.42, 41.43), liver
resection (50.2, 50.21-26, 50.29, 50.3), pancreas resection
(52.5, 52.51-53, 52.59, 52.6, 52.7), bowel or colon resec-
tion (45.5, 45.50-52, 45.61-62, 45.7, 45.71, 45.73-76,
45.79, 45.8, 45.81-83), or thrombectomy with vascular
reconstruction (37.10, 38.05, 38.07, 38.45, 38.47, 38.65,
38.67, 38.75, 38.77, 38.87, 39.6, 39.61, 39.63, 39.66) to re-
duce the potential for bias by burden of disease.
Other kidney surgery
The ICD-9 procedure code for nephrectomy does not
distinguish between radical and simple operations. Conse-
quently, we excluded all patients with a concomitant ICD-
9 diagnosis code for kidney donor (V59.4), and infectious
etiologies including acute and chronic pyelonephritis
(590.0, 590.00, 590.01, 590.1, 590.10 and 590.11) and renal/
perinephric abscess (590.2) since these diagnoses might
represent the indication for performing the procedure. We
also excluded those patients with a diagnosis of renal pelvic
or ureteral tumor (189.1 or 189.2) since nephrectomy and
nephroureterectomy utilize the same ICD-9 procedure
code. We also excluded autosomal dominant polycystic
kidney disease (753.12, 753.13, 753.14) since the diagnosis
might affect pre-operative renal function as well as surgical
indication and selection.
Comorbidity and chronic kidney disease
Co-morbid conditions assessed include hypertension
(Dx CCS 98, 99), diabetes (Dx CCS 49, 50) and obesity
(ICD-9 278.0, 278.01, 278.00). A subgroup analysis of
Liss et al. BMC Urology 2014, 14:101 Page 3 of 10
http://www.biomedcentral.com/1471-2490/14/101patients with a discharge ICD-9 diagnosis of chronic
renal insufficiency (585x) was performed. We divided
patients with a specified CKD stage into those with end
stage renal failure (ESRF) requiring dialysis (CKD stage
5, ICD-9 585.5). CKD 6 is an unspecified diagnosis code
of 585.6; however, most patients fell into this category
possibly due to coding indiscretion to CKD stage.
Statistical analysis
The 20% NIS sample was weighted to estimate all na-
tional inpatient stays and used for all calculations. The
primary outcome of proportion of PN performed 2 years
before (November 2007-October 2011) and 2 years fol-
lowing (November 2009-October 2011) publication of
Guideline for management of the clinical T1 renal mass
(AUA Renal Mass Guideline) was examined by the Chi
Squared test. The secondary outcome was change in
rates of PN over the two time periods were calculated
using the total number of inpatients in each year creat-
ing simple linear regression models to approximate the
change in procedure incidence over time (months). The
proportion of PN performed was calculated by the num-
ber of partials performed divided by the total number of
nephrectomies (RN plus PN). Each time period will have
a regression statistical value then the slopes are com-
pared using interactions between the regression lines.
Demographics, clinical and hospital characteristics were
compared between groups using chi-squared (Rao & Scott
second order correction), ANOVA, and Student t tests
(using Bonferroni correction for inter-group comparisons).
We grouped patients based on RN vs. PN as well as pre
vs. post AUA T1 Renal Mass Guidelines recommendation
to examine demographic differences. Because renal mass
treatment may be influenced by age we included age as a
continues variable as well as a binary variable at age 60 as
this was the median age of partial nephrectomy in the
AUA guidelines [15]. Additionally, racial differences are
compared due to recent evidence that race and gender
may influence surgical decision making [16,17].
Subsequently, we performed multivariable analysis using
binary logistic regression models to examine the influence
of age, race, sex, co-morbid disease and hospital character-
istics on surgery selection; only variables that reached
statistical significance in the multivariate model were ul-
timately included in the final models. SVY coding in
STATA v 11.1 (StataCorp, College Station, TX) was used
to account for NIS sampling methodology, and probability
of type I error was defined a priori as α = 0.05.
Results
Population characteristics for partial nephrectomy pre
and post guidelines
We identified 95,711, patients undergoing either PN or
Radical Nephrectomy (RN) in the United States fromNovember 2009 to October 2011. We compared 30,944
patients who received a PN to 64,767 who received a RN
(Table 1). A significantly higher proportion of PN was
performed after 2 years after AUA Renal Mass Guideline
publication compared to two years prior guidelines were
published than prior (35.3 % vs. 29%; p < 0.0001). Patients
with CKD who underwent PN was not significantly in-
creased post-guidelines compared to pre-guideline (7.3%
vs. 7.9%; p = 0.2997). More specifically, 26.3% (626/2376)
PN were performed prior to guideline publication with
Stage III/Stage IV CKD compared 28.2% (970/3439) to
post-Guideline publication which corresponds to a non-
significant increase (p = 0.126).
Regarding ethnicity/racial demographics, increased PN
were noted in Caucasian, African-American, Hispanic,
and Asian patients from 28.9%, 28.4%, 25.1%, 26.1% be-
fore the guidelines and 35.6%, 33.3%, 32.7%, and 32.3%
after Guideline publication, respectively (p < 0.001). The
largest improvement was 7.6% occurring in the Hispanic
population. Proportionally, more PN were performed in
patients with diabetes (20.8% vs. 23.3%; p = 0.005) and
obesity (12.8% vs. 15.1%; p = 0.011). Less PN were per-
formed at hospitals that performed less than 25 renal
surgeries per year (82.6% vs. 62.2%; p < 0.0001). Despite
the improvement length of stay in the hospital (3.1 days
vs. 2.7 days; p < 0.001), the expense of PN increased by
$3,158 (USD; p < 0.0001).
Population characteristics for partial nephrectomy vs.
radical nephrectomy
We identified many discrepancies between the demo-
graphics of patients who received a RN compared to a
PN (Table 2). Non-modifiable factors for radical neph-
rectomy patients would include age and multiple comor-
bidities (both p < 0.001). We show social factors may
play role in surgical preference because hospital location,
hospital volume, and patient wealth (insurance and zip
code) were all highly significant factors in our study.
Multivariate analysis of pre and post AUA T1 renal mass
guidelines publication
Using logistic regression analysis, patients had a 24% in-
creased odds of having a PN after Guideline publication
(OR 1.242 95%CI 1.001-1.542; p = 0.0489) More PN were
performed on obese patients (OR 1.527 95%CI 1.113-
2.058; p = 0.0054). Lastly, patients who had surgery at a
hospital that does at least 25 nephrectomies (partial or
radical) had a 2-fold higher odds of having a PN after
Guideline publication than prior (p < 0.0001)
Trends of partial nephrectomies in relation to guideline
release
The overall proportion of PN performed from increased sig-
nificantly throughout the study period (R2 = 0.24; p = 0.0005;
Table 1 Patient demographics of partial nephrectomy before and after the publication of the T1a renal AUA guidelines
recommendations
Demographic Before Guidelines After Guidelines p-value
N = 27357 (PN) N = 34336 (PN)
N = 94457 (PN + RN) N = 97314 (PN + RN)
Mean Age ± SE 58.2 ± 0.2 58.4 ± 0.2 0.3888
Age Group 0.3325
<60 14024(51.3) /44364 17228(50.2) /45978
≥60 13333(48.7) /50093 17108(49.8) /51336
Gender 0.1857
Male 15558(57.1) /53780 20015(58.4) /56715
Female 11672(42.9) /40344 14245(41.6) /40406
Race <0.0001
Caucasian 16714(61.1) /57803 23530(68.5) /66065
African-American 2059(7.5) /7244 3190(9.3) /9575
Hispanic 1540(5.6) /6125 2489(7.3) /7609
Asian 440(1.6) /1681 567(1.7) /1752
Other 6604(24.1) /21604 4558(13.3) 12313
Income (Zip Code) 0.8705
<$50,000 12000(45.1) /44943 15053(44.7) /46743
≥$50,000 14609(54.9) /47486 18634(55.3) /48732
Hypertension 15427(43.6) /56001 20009(58.3) /59732 0.0842
Diabetes 5702(20.8) /20288 7998(23.3) /23219 0.0056
Obesity 3493(12.8) /10846 5180(15.1) /13513 0.0114
Chronic Kidney Disease 1986(7.3) /12058 2697(7.9) /13685 0.2997
CKD Stages 0.6560
Stage1 10(0.5) /25 30(1.1) /75 0.2353
Stage2 83(4.2) /353 124(4.6) /439 0.5822
Stage3 480(24.2) /1770 766(28.4) /2620 0.1144
Stage4 146(7.3) /606 204(7.6) /819 0.6660
Stage5/ESRD 15(0.8) /182 24(0.9) /163 0.7484
Stage unspecified 1252(63.0) /9121 1548(57.4) /9568 0.9392
Charlson Comorbidity Index 0.3327
0 16780(61.3) /52204 20528(59.8) /53063
1 6763(24.7) /21901 8965(26.1) /23394
2 1948(7.1) /7365 2375(6.9) /7594
3+ 1866(6.8) /12988 2468(7.2) /13262
Insurance 0.8561
Private 15224(55.8) /45206 18797(54.9) /45917
Medicare 9018(33.0) /37728 11416(33.3) /38316
Medicaid 1561(5.7) /5794 2014(5.9) /6464
Other 1500(5.5) /5565 2031(5.9) /6352
Hospital Bed Number 0.3397
Small 2350(8.8) /8298 3077(9.2) /8808
Medium 5742(21.5) /20598 5766(17.2) /18948
Large 18569(69.6) /63430 24696(73.6) /67702
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Table 1 Patient demographics of partial nephrectomy before and after the publication of the T1a renal AUA guidelines
recommendations (Continued)
Hospital Nephrectomy Volume/year <0.0001
<25 737(82.6) /4159 824(62.2) /4065
25-49 88(9.9) /417 273(20.6) /886
50-99 43(4.8) /189 140(10.6) /418
100+ 24(2.7) /73 88(6.6) /190
Hospital Location 0.4592
Rural 1128(4.2) /5236 1205(3.6) /5467
Urban 25534(95.8) /87089 32334(96.4) /89992
Hospital Region 0.8938
Northeast 6041(22.6) /17794 8283(24.5) /19444
Midwest 7309(27.3) /24490 9413(27.9) /26002
South 7699(28.8) /29451 9983(29.6) /31888
West 5692(21.3) /20876 6104(18.1) /18747
Teaching 0.4759
Non-teaching 6482(24.3) /31172 8920(26.6) /31383
Teaching 20180(75.7) /61153 24619(73.4) /64075
Median Length of Stay (IQR), days 3.1(2.1-4.4) 2.7(1.7-3.9) <0.0001
Median Total Charges for Stay (IQR), $ 35223(24931–49394) 38381(27440–55923) <0.0001
Died during hospitalization 45(0.2) /703 50(0.1) /774 0.8318
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gression lines to determine the rate of change of PN per-
formed prior to Guideline publication (R2 = 0.40 p = 0.0007)
and after Guideline publication (R2 = 0.30 p = 0.0041).
We then compared the interaction between the regres-
sion lines noting they were not statistically different
(p = 0.4613). Figure 1 displays the trends over time.
There was no increase in PN for patient with CKD over
this time period (R2 0.0007, p = 0.8592) or between the
two time periods (R2 0.02 vs. 0.04; p = 0.2425). Linear
regression could not be performed on specifically CKD
stage III/IV due to low sample size leading to potentially
large error.
Discussion
We noted a 6.4% absolute increase in the proportion of
PN in a two-year period performed before and after the
guideline release; however, PN remains only about 35%
of all nephrectomies performed. We used an adjusted
multivariable analysis to identify a 23% increased odds of
having a PN in the 2 years after Guidelines publication
(Table 3). We were expecting to identify a rise in the rate
of PN after Guideline publication, however there was no
difference in incidence (Figure 1). While increase in PN
utilization increase after AUA T1 Renal Mass guidelines
publication was recently reported by Bjurlin et al. who
noted a one year increase in PN proportion from 27% to
32% [18], our data are longer term and the conclusionswe draw while seemingly similar (i.e., an overall in-
crease). Nonetheless our results demonstrate that in-
crease in PN utilization was more likely due to the
overall steady rise in incidence over time rather than the
AUA T1 Renal Mass Guidelines making a significant im-
mediate impact (Figure 1). We describe increases in PN
for high risk patients such as those with obesity, dia-
betes, and hypertension. Unfortunately, we noted no
change in PN proportion with preoperative non-dialysis
dependent CKD before and after the AUA T1 Renal
Mass Guideline publication (Figure 2). While we are un-
able to target specific reasoning behind the lack of in-
crease in partial nephrectomy among non-dialysis
depended CKD patients, such as tumor factors, this
finding is concerning considering it is highlighted as an
imperative indication of PN in the Guidelines [15].
Moreover, the AUA guideline is similar to the EAU
guidelines regarding treatment of renal mass with prefer-
ence toward nephron sparing surgery (initially published
in June, 2007 with update in 2010) [19,20]. We highlight
this finding as a potential quality of care issue which de-
serves further follow up.
Patients presenting with a renal mass and concurrent
CKD are at highest risk of renal related morbidity and
mortality [21-23]. However, our study shows the United
States continues to struggle to provide PN to patients
because of social issues such as the patient’s financial
means and where they reside, which agrees with reports
Table 2 Patient demographics comparing partial nephrectomy and radical nephrectomy over the 4 year study period
Demographics Partial Nephrectomy Radical Nephrectomy p-value
N = 61693 N = 130078













Income (Zip Code) <0.0001
<$50,000 27052(44.9) 64633(50.6)
≥$50,000 33242(55.1) 62976(49.4)
Hypertension 35436(57.4) 80297(61.7) <0.0001
Diabetes 13701(22.2) 29806(22.9) 0.1767
Obesity 8673(14.1) 15687(12.1) <0.0001
Chronic Kidney Disease 4683(7.6) 21060(16.2) <0.0001
CKD Stages <0.0001
Stage 1 40(0.9) 60(0.3) 0.6139
Stage 2 206(4.4) 586(2.8) 0.0421
Stage 3 1246(26.6) 3144(14.9) 0.0004
Stage 4 350(7.5) 1075(5.1) 0.0009
Stage 5 / ESRD 40(0.8) 306(1.5) <0.0001
Stage unspecified 2800(59.8) 15890(75.4) <0.0001














Hospital Nx Volume/year <0.0001
<25 1560(70.4) 6663(81.5)
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Median Length of Stay (IQR), days 2.9(1.9-4.2) 3.4(2.2-5.2) <0.0001
Median Total Charges for Stay (IQR), $ 36832(26298–53058) 37359(25669–59124) <0.001
Died during hospitalization 93(0.2) 1384(1.1) <0.0001
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care data [24]. Recent health reform in American health-
care may change these trends and should be followed
over time [25]. Despite current changes in healthcare, is-
sues such as access to care, appropriate training, and
hospital resources are also concerns for urologists. ForFigure 1 Incidence of PN performed as a proportion of nephrectomie
Inpatient Sample from November 2007 to October 2011 noting when
publication date.example, urologists were criticized for poor adherence
to guideline recommendations regarding a lower than
anticipated use of intravesical chemotherapy for non-
muscle invasive bladder cancer in population studies
[26]. However when thoroughly investigated to improve
care, the investigators found that the initial the baselines (radical and partial) performed in the United States Nationwide
the T1a Renal AUA Guidelines Recommendation
Table 3 Multivariable analysis comparing partial nephrectomy vs. radial nephrectomy using the 2 year study period
prior to publications of the T1a renal AUA guidelines recommendations as reference
Before AUA T1 Renal Guideline (reference) vs. After AUA T1 Renal Guideline
Odds Ratio 95% Wald Confidence Limits P Overall P
Partial Nephrectomy vs. Radical Nephrectomy (reference) 1.242 1.001 - 1.542 0.0489
<0.0001
Obesity Yes vs. No (reference) 1.527 1.133 - 2.058 0.0054
Nephrectomy Hospital Volume Less than 25 cases (reference)
<0.0001
Volume 25–49 cases 2.09 1.600 -2.731
Volume 50–99 cases 2.222 1.535 - 3.217
Volume 100+ cases 2.566 1.430 - 4.605
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true reasons for not performing a PN also need to be
studied in a similar fashion to the studies regarding non-
muscle invasive bladder cancer, potentially a utilization
of the newly developed American Urologic Association
Quality Registry (AQUA).
Another potential reason for lack of increased adop-
tion of PN for T1 renal neoplasms is that the seemingly
overwhelming and robust retrospective data supporting
PN has been called into question by publication of only
prospective randomized randomized trial to address this
topic, EORTC 30904, which was published in April
2011. This trial randomized 541 patients [PN (n = 268)/
RN (n = 273)], with a median follow-up of 9.3 years, and
noted that overall survival with a hazard ratio (HR) of
1.50, testing for non-inferiority was not significant (p =Figure 2 Incidence of PN performed in patients with preoperative ch
and partial) performed in the United States Nationwide Inpatient Sam
Guidelines Recommendation Release.0.77), and test for superiority was significant (p = 0.03) in
favor for RN, though in RCC patients there were no sig-
nificant differences with respect to overall survival.
These findings were presented cautiously given short-
comings in study design and execution [13], however,
they have already generated a great deal of controversy
amongst thought leaders [18,22,23]. For the observation
period and our analysis however, the impact of this study
and its findings are likely limited and not noted. Indeed,
longer observation is requisite to evaluate the impact of
this study both on practice patterns in the United States,
as well as in the formulation of updates to the AUA
Guidelines document.
The criticism for PN utilization of only 35% in this
population based cohort is tempered by the overall rise
in incidence of PN in the past 4 years as well as the lackronic kidney disease as a proportion of nephrectomies (radical
ple from November 2007 to October 2011 noting when the AUA
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making. We identified the largest improvement in PN
performed based on hospital volume. In multivariable
analysis, patients had a 2 fold increased odds chance of
having a PN if the hospital performs at least 25 renal
cases (partial or radical nephrectomies) per year con-
firming results of prior studies using the NIS [28]. Vari-
ous reasons may account for this increase. Some reasons
for the change in volume may include lower volume
hospitals increasing number of PN performed, reflection
of current referral patterns, and a combination of both.
Additionally, PN in obese patients increased as which
most likely is reflecting the increasing obesity epidemic
in the United States, which is likely a welcome develop-
ment given the fact that obesity is a driver for CKD as
well [29].
We performed this study not to determine causality of
the AUA T1 Renal Mass Guidelines on PN in the United
States, but to identify potential opportunities for im-
provement. Creation of a guideline should only be the
beginning of a continuous process of improvement as
the ultimate success of depends on critical evaluation
over time [30]. In general, guidelines are data driven
documents that provide assistance to physicians and
come after a majority of the physicians have already
adopted the practice [31]. PN has been performed for
more than a century, yet continued debate remains re-
garding its benefit and utilization [13,32,33]. The adop-
tion of PN may be due in part to changes in technology
such as laparoscopy and robotic surgery [4,7]. Indeed
our findings that the median hospital length of stay has
decreased while there may be a rise in overall cost of
procedure for PN, while likely indicative increasing
adoption of minimally invasive partial nephrectomy (lap-
aroscopic or robotic) our group has reported in previous
studies [34,35].
Limitations in the data derived from national databases
are only as accurate as the codes that have been chosen
for the patient. The NIS database does not have pathologic
data and therefore may not solely focus on cT1a renal cor-
tical masses. However, the NIS was chosen for its strength
in the documentation of the procedure itself as well as the
fact that up to 25% of small renal masses have benign hist-
ology, and would therefore not be documented in oncol-
ogy driven databases [15]. Moreover, the pathology of the
renal mass is usually not available to the surgeon prior to
the decision for type of surgery, and we sought to examine
trends in procedure utilization as opposed to oncologic
outcomes. Though only 4 years are evaluated in our ana-
lysis, it is possible that tumor stage may have changed over
time and could confound the analysis. We have provided
extensive exclusion criteria to remove patients with ad-
vanced tumors from our analysis, which have been vali-
dated by our group and others in previous analyses[6,20,24]. Furthermore, CKD can be a generalized term
and we did note variation within the CKD stages 2–5
codes. Nonetheless, the rate of CKD in patients undergo-
ing RN or PN was 4.4% overall, which is similar in rate to
the 4.3% prevalence of CKD Stage 1–4 reported in medi-
care patients and suggests that there is no coding bias fa-
voring reporting of dialysis dependent CKD over CKD
Stages 1–4. More specific and accurate determination and
documentation of CKD are needed for patients presenting
for PN for appropriate counseling.
Partial nephrectomy utilization has increased over the
4 years selected for evaluation and should be recognized.
However, the lingering question is how many present
with amenable tumors and/or various indications for
partial nephrectomy and do not have the option offered.
One such patient’s are those with CKD, in which a surgi-
cal decision could have significant impact on future
health in which the urologists is not likely to serve the
penalty. Therefore, a concerted effort should be placed
on identifying patients who would most benefit from
partial nephrectomy and providing that service despite
demographic challenges. Additionally, further investiga-
tion regarding current clinical decision may provide
more immediate problem solving opportunities.Conclusions
We have identified a steady increase in PN over the
four-year study period and more PN performed after the
publication of the AUA Clinical T1 Renal Mass Treat-
ment Guidelines. However, the rate of PN performed
after the guidelines release was not faster indicating that
other factors may be influencing the adoption of PN.
Additional studies and longer-term follow up are needed
to determine the practical effects and clinical signifi-
cance of evidence-based guidelines.
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